|Articles|June 16, 2020
- PharmTech Sponsored eBooks-07-20-2020
- Volume Sponsored eBook
- Issue 10
Identifying and Quantifying Mutagenic Impurities in Pharmaceutical Products
Meeting detection challenges presented by nitrosamine impurities Determination of NDMA and nitrosamine impurities using triple-quadrupole LC/MS Determination of genotoxic impurities in ranitidine APIs and drug products
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
European Parliament Revamps Pharmaceutical Policy Framework
2
EMA Calls New EU Pharma Legislation Most Significant in Two Decades
3
Regulatory Expectations for Evaluating GMP Facilities and Equipment
4
Tjoapack’s Advanced Packaging Expansion Aims to Meet Rising Demand
5
